Kairosoft AI Solutions to table results

Mumbai, Aug. 3 -- Kairosoft AI Solutions will hold a meeting of the Board of Directors of the Company on 5 August 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

GR Infraprojects to table results

Mumbai, Aug. 3 -- GR Infraprojects will hold a meeting of the Board of Directors of the Company on 6 August 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

Rollatainers schedules board meeting

Mumbai, Aug. 3 -- Rollatainers will hold a meeting of the Board of Directors of the Company on 5 August 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

Sustainable travel gains momentum among Vietnamese tourists: Booking.com report

Hanoi, Aug. 3 -- Sustainable tourism is becoming a defining trend among Vietnamese travellers as they increasingly seek to balance memorable experiences with positive contributions to local communitie... Read More

Greaves Electric Mobility successfully raises Rs 530 cr via rights issue

Mumbai, Aug. 3 -- Greaves Electric Mobility (GEML) announced an additional equity infusion of Rs 530 crore through a rights issue. The investment is fully subscribed by the existing shareholders in pr... Read More

मूलांक 6 राशिफल 3 अगस्त 2026: नई सोच अपनाएंगे तो खुलेंगे तरक्की के नए रास्ते

नई दिल्ली, अगस्त 3 -- मन के भीतर एक नरम सा बदलाव महसूस हो सकता है। जिन लोगों से आपकी राय नहीं मिलती, उनकी बात भी इस बार सुनने लायक लगेगी। 3 अगस्त 2026 को मूलांक 3 और भाग्यांक 3 की ऊर्जा बातचीत, सीख और... Read More

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Aug. 3 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared with Pembrolizumab monotherapy in participants with advanced colorectal adenocarcinoma (CRC) harboring microsatellite instability (MSI) and/or deficient mismatch repair (DMMR)

Singapore, Aug. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Study of VVD-133214 in Combination with Pembrolizumab compared wi... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Aug. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherap... Read More

Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Aug. 3 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... Read More

• ««
• «
• 740
• 741
• 742
• 743
• 744
• 745
• 746
• 747
• 748
• 749
• »
• »»